Transcatheter heart valves technologies

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation

Published on 16/06/2022 | van Nieuwkerk et al. | The American Journal of Cardiology 2022; 172(1 June 2022): 81-9 | 0 minute read

Transcatheter heart valves technologies

Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement

Published on 02/06/2022 | Panagides et al. | International Journal of Cardiology 2022; 358(1 July 2022): 12-6 | 0 minute read

Transcatheter heart valves technologies

Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost‐Utility Analysis

Published on 19/05/2022 | John K. Peel MD 1 et al. | Journal of the American Heart Association 2022; 11(8): 025085 | 31 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive therapy for patients with severe aortic stenosis, which has

Transcatheter heart valves technologies

Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study

Published on 19/05/2022 | Kawakami et al. | Circulation: Cardiovascular Interventions 2022; 15(4): e011358 | 8 minute read

Indications for transcatheter aortic valve replacement (TAVR) have expanded to aortic stenosis patients with low- and intermediate-risk of surgery.1 Post-TAVR

Transcatheter heart valves technologies

Transcatheter aortic valve implantation in patients with rheumatic aortic stenosis

Published on 05/05/2022 | Taishi Okuno 1 et al. | Heart 2022; aop:10.1136/heartjnl-2021-320531 | 22 minute read

Abstract Background Rheumatic heart disease (RHD) accounts for the highest number of deaths from valvular heart disease globally. Yet, rheumatic

Transcatheter heart valves technologies

Wearable Smartwatch Facilitated Remote Health Management for Patients Undergoing Transcatheter Aortic Valve Replacement

Published on 21/04/2022 | Xianbao Liu MD et al. | Journal of the American Heart Association 2022; 11(7): 023219 | 19 minute read

Abstract Background In the recent decades, the development of novel digital health technologies enables doctors to monitor ECG and vital

Transcatheter heart valves technologies

Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis

Published on 21/04/2022 | Francesca Graziani 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.13846 | 27 minute read

Abstract Aims There are limited data about the intraprocedural haemodynamic study performed immediately before and after transcatheter aortic valve implantation

Transcatheter heart valves technologies

Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J‐TVT

Published on 07/04/2022 | Tsuyoshi Kaneko MD 1 et al. | Journal of the American Heart Association 2022; 11(6): 023848 | 25 minute read

Abstract Background The practice pattern and outcome of medical devices following their regulatory approval may differ by country. The aim

Transcatheter heart valves technologies

One‐year results following PASCAL‐based or MitraClip‐based mitral valve transcatheter edge‐to‐edge repair

Published on 21/03/2022 | Nicolas A. Geis 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.13849 | 25 minute read

Abstract Aims Mitral valve transcatheter edge‐to‐edge repair (TEER) has been established as a suitable alternative to mitral valve surgery in

Transcatheter heart valves technologies

Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database

Published on 21/03/2022 | Ayman ElbadawiMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30072 | 16 minute read

Abstract Background There is a paucity of data regarding the sex‐related differences in the trends and outcomes of trans‐septal transcatheter

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.